Symposium 01 : November 19 (Thu), 09:00-10:30
Distinguished studies in hepatology: Reading the year — What truly mattered in 2025–2026?, and what comes next

• Viral hepatitis: From viral suppression to long-term outcomes Eun Ju Cho
  Seoul National University, Korea CV 즐겨찾기
• MASLD & MetALD: A paradigm shift, not just a name change Dae Won Jun
  Hanyang University, Korea CV 즐겨찾기
• HCC: More drugs, harder decisions Young Youn Cho
  Chung-Ang University, Korea 즐겨찾기
• Portal hypertension: Redefining risk and decompensation Sang Gyune Kim
  Soonchunhyang University, Korea CV 즐겨찾기

Symposium 02 : November 19 (Thu), 09:00-10:30
Recent advances in third space endoscopy

• Recent advances in esophageal POEM In Kyung Yoo
  CHA University, Korea CV 즐겨찾기
• G-POEM: Standardizing outcomes and comparing surgical alternatives Ping-Hong Zhou
  Fudan University, China CV 즐겨찾기
• Endoscopic resection method for upper GI SET: A practical guide Bong Eun Lee
  Pusan National University, Korea CV 즐겨찾기
• Recent advances in minimally invasive full-thickness resection technique Chan Gyoo Kim
  National Cancer Center, Korea 즐겨찾기

Symposium 03 : November 19 (Thu), 09:00-10:30
2026 GERD debates: Controversies and frontiers

• GERD in Rome V: Redefining boundaries between reflux disease and DGBI Chien-Lin Chen
  Hualien Tzu Chi Hospital, Taiwan CV 즐겨찾기
• PPI-refractory GERD: Phenotypes, not failures Chung Hyun Tae
  Ewha Womans University, Korea CV 즐겨찾기
• PCAB vs PPI: Are we ready to change the standard of care? Kyoungwon Jung
  Kosin University, Korea CV 즐겨찾기
• Beyond medication: Tailoring surgical and endoscopic therapy in GERD Hyun Lim
  Hallym University, Korea CV 즐겨찾기

Basic/Translational Symposium : November 19 (Thu), 09:00-10:30
Circulating & spatial biomarkers in GI cancer: From detection to treatment selection

• ctDNA dynamics for minimal residual disease and early relapse detection Yongjun Cha
  Kangwon National University, Korea CV 즐겨찾기
• Exosome/EV-based biomarkers for drug response and resistance Dong Uk Kim
  CHA University, Korea 즐겨찾기
• Spatial analysis of cancer-derived extracellular vesicles in metastatic tissue microenvironments Nao Nishida-Aoki
  Waseda University, Japan 즐겨찾기
• Immune-based biomarkers in colorectal cancer: From spatial immune profiling to circulating TCR dynamics Yong Joon Lee
  CHA University, Korea 즐겨찾기

Symposium 04 : November 19 (Thu), 09:00-10:30
AI and microbiome research in gastric cancer

• AI-assisted endoscopy for early gastric cancer detection and prediction of invasion depth Yuna Kim
  Yonsei University, Korea 즐겨찾기
• AI-aided gastric cancer risk assessment in endoscopy Donghoon Kang
  The Catholic University of Korea, Korea CV 즐겨찾기
• Non-Helicobacter microbiome and gastric carcinogenesis Jin Won Chang
  Yonsei University, Korea CV 즐겨찾기
• Microbiome-based approaches from biomarkers to treatment in gastric cancer Cheol Min Shin
  Seoul National University, Korea 즐겨찾기

Presidential lecture : November 19 (Thu), 10:50-11:20
Chung Yong Kim memorial lecture

• Walking alongside patients: A clinical investigator's journey through the hepatitis C era Sook-Hyang Jeong
  Seoul National University, Korea CV 즐겨찾기

Symposium 05 : November 19 (Thu), 10:50-12:20
Modern big data research into real-world gastroenterology practice

• Data-driven insights: Research strategies with K-CURE big data Joon Sung Kim
  The Catholic University of Korea, Korea 즐겨찾기
• Advancing big data research: Global databases and genomic data approaches Moon Haeng Hur
  Seoul National University, Korea CV 즐겨찾기
• Strategies for high-impact big data research: Differentiation in the age of AI Seung Won Lee
  Sungkyunkwan University, Korea CV 즐겨찾기
• Practical clinical big data research in real world: From A to Z Su Young Kim
  Yonsei University Wonju, Korea 즐겨찾기

Symposium 06 : November 19 (Thu), 10:50-12:20
The first five years in IBD: Getting it right from the start

• Choosing the first advanced agent: Strategic positioning of biologics and small molecules in Crohn’s disease Shaji Sebastian
  Hull University, UK CV 즐겨찾기
• Choosing the first advanced agent: Strategic positioning of biologics and small molecules in ulcerative colitis Ren Mao
  The First Affiliated Hospital of Sun Yat-sen University, China CV 즐겨찾기
• Tight control in practice: Operationalizing treat-to-target Sung Wook Hwang
  University of Ulsan, Korea CV 즐겨찾기
• De-escalation and maintenance strategy: When to step down and when to hold the line Sang-Bum Kang
  The Catholic University of Korea, Korea CV 즐겨찾기

Symposium 07 : November 19 (Thu), 10:50-12:20
Regional phenotypes and contemporary management of chronic pancreatitis

• Clinical phenotypes and diagnostic approach to chronic pancreatitis Jaihwan Kim
  Seoul National University, Korea CV 즐겨찾기
• Endoscopic management of stone-predominant chronic pancreatitis Sundeep Lakhtakia
  Asian Institute of Gastroenterology, India 즐겨찾기
• Endoscopic management of ductal stricture-dominant chronic pancreatitis Hirofumi Kogure
  Nihon University, Japan CV 즐겨찾기
• Long-term management of chronic pancreatitis: Nutrition, diabetes, and cancer risk Min Kyu Jung
  Kyungpook National University, Korea CV 즐겨찾기

Symposium 08 : November 19 (Thu), 10:50-12:20
New horizons in upper GI cancer management

• Current evidence comparing ESD and surgery in undifferentiated early gastric cancer Kee Don Choi
  University of Ulsan, Korea CV 즐겨찾기
• Predicting outcomes after ESD of early gastric cancer Tae-Se Kim
  Sungkyunkwan University, Korea CV 즐겨찾기
• Endoscopic eradication therapy for Barrett's esophagus Dong Chan Joo
  Pusan National University, Korea CV 즐겨찾기
• ESD for early esophageal cancer Da Hyun Jung
  Yonsei University, Korea 즐겨찾기

Symposium 09 : November 19 (Thu), 13:20-14:50
Contemporary approaches to chronic liver disease

• Portal hypertension: From fundamental concepts to Baveno VIII consensus Do Seon Song
  The Catholic University of Korea, Korea 즐겨찾기
• Antisense oligonucleotide therapy for CHB: Clinical realities between hope and hype Eun Sun Jang
  Seoul National University, Korea CV 즐겨찾기
• The changing epidemiology of chronic liver disease in the MASLD era: Lessons from US and global data Donghee Kim
  Stanford University, USA CV 즐겨찾기
• Redefining cirrhosis to cACLD through non-invasive diagnostics Vincent Wong
  Chinese University of Hong Kong, Hong Kong CV 즐겨찾기

Combined Symposium 01 (KSG+KSSO) : November 19 (Thu), 13:20-14:50
Obesity and gastrointestinal diseases: From inter-organ crosstalk to cancer and therapy

• The gut–liver–adipose axis: Integrating metabolism, immunity, and microbiome Jun Hwa Hong
  Eulji University, Korea 즐겨찾기
• Obesity as an oncogenic driver: Implications for gastrointestinal cancers Joon Ho Moon
  Seoul National University, Korea 즐겨찾기
• GI consequences of anti-obesity medications: What gastroenterologists need to know Sung Won Chung
  University of Ulsan, Korea 즐겨찾기
• Bariatric surgery in the era of GLP-1 receptor agonists: Competition or complement? Sang Hyun Kim
  Soonchunhyang University, Korea CV 즐겨찾기

Symposium 10 : November 19 (Thu), 13:20-14:50
Personalizing comprehensive care in IBD

• Tailoring therapeutic strategies for the aging IBD population Taku Kobayashi
  Kitasato University, Japan CV 즐겨찾기
• Integrating mental health into comprehensive IBD care Hyuk Yoon
  Seoul National University, Korea CV 즐겨찾기
• Vaccination strategies and infection prevention in IBD Dae Sung Kim
  Konyang University, Korea CV 즐겨찾기
• Individualized approaches to perianal fistula management Eun Jung Park
  University of Ulsan, Korea CV 즐겨찾기

Symposium 11 : November 19 (Thu), 13:20-14:50
Upper GI leaks & fistulas: Algorithm-based treatment and advanced endoscopic therapies

• Endoscopic therapies for upper GI leaks: Clips, stents, vacuum therapy, and internal drainage Hee Seok Moon
  Chungnam National University, Korea CV 즐겨찾기
• Nutritional and supportive management in upper GI leaks: Jejunal feeding, TPN, and sepsis pathways Seung Wan Ryu
  Keimyung University, Korea CV 즐겨찾기
• Interventional radiology in upper GI leaks: When endoscopy is not enough Ji Hoon Shin
  University of Ulsan, Korea CV 즐겨찾기
• Algorithm for managing upper GI leaks & fistulas: From initial assessment to treatment selection Naoya Tada
  Kagawa University/The Jikei University, Japan CV 즐겨찾기

Symposium 12 : November 19 (Thu), 13:20-14:50
Treatment beyond progression: New concepts in refractory GI cancers

• Biologic rationale of treatment beyond progression in pancreatic cancer Hee Seung Lee
  Yonsei University, Korea 즐겨찾기
• Rechallenge, switch, or combine: Strategic sequencing of systemic therapy in colorectal cancer Eun Sun Kim
  Korea University, Korea 즐겨찾기
• Predicting and preventing early metastasis after curative surgery for gastrointestinal cancer Hyunjeong Ki
  Chungnam National University, Korea 즐겨찾기
• Surgical and intraperitoneal approaches for refractory pancreatobiliary cancer Travis E. Grotz
  Mayo Clinic, USA CV 즐겨찾기

Symposium 13 : November 19 (Thu), 13:20-14:50
Clinical updates and decision making for Helicobacter pylori eradication

• 2026 Korean guideline: Key updates Chang Seok Bang
  Hallym University, Korea CV 즐겨찾기
• Korea registry on the current management of H. pylori Hyo-Joon Yang
  Sungkyunkwan University, Korea 즐겨찾기
• Antibiotics resistance and role of susceptibility-guided therapy Ji Yong Ahn
  University of Ulsan, Korea CV 즐겨찾기
• Emerging strategies in vonoprazan-based therapy and resistance patterns in Japan Hidekazu Suzuki
  Tokai University, Japan CV 즐겨찾기

Symposium 14 : November 19 (Thu), 15:10-16:40
First-line (1L) systemic therapy for HCC: Beyond the choice—strategy, sequencing, and synergy

• 1L treatment debate – Why immunotherapy (IO)+anti-angiogenics first? Pil Soo Sung
  The Catholic University of Korea, Korea CV 즐겨찾기
• 1L treatment debate – Why dual IO first? Thomas Yau
  The University of Hong Kong, Hong Kong 즐겨찾기
• Treatment selection using multiomics Jihyun An
  Hanyang University, Korea 즐겨찾기
• Multi-modal strategies for advanced HCC Naoshi Nishida
  Kindai University, Japan CV 즐겨찾기

Combined Symposium 02 (KCHUGR+KSNM) : November 19 (Thu), 15:10-16:40
Managing uncertainty in the upper GI tract through gray zones and near-miss cases

• Managing borderline gastric biopsy findings and clinical decision-making Ga Hee Kim
  Yonsei University, Korea CV 즐겨찾기
• Missed early gastric cancer on endoscopy lessons from near-miss cases Joo Hyun Lim
  Seoul National University, Korea CV 즐겨찾기
• Functional dyspepsia and gastroparesis: Distinct entities or a diagnostic gray zone? Eun Jeong Gong
  Hallym University, Korea CV 즐겨찾기
• Near misses in esophageal motility disorders (or functional esophageal disorders): When tests are inconclusive Kee Wook Jung
  University of Ulsan, Korea 즐겨찾기

Multidisciplinary Symposium 01 : November 19 (Thu), 15:10-16:40
Redefining resectability in pancreatic cancer

• Borderline resectable pancreatic cancer after neoadjuvant therapy: Surgical perspective Yoo-Seok Yoon
  Seoul National University, Korea 즐겨찾기
• Radiation strategies to convert unresectable to resectable disease Hyun-Cheol Kang
  Seoul National University, Korea CV 즐겨찾기
• Systemic therapy as a bridge to curative surgery Chien-Jui Huang
  National Cheng Kung University, Taiwan 즐겨찾기
• Multidisciplinary decision algorithms and real-world outcomes Sung Jun Jo
  CHA University, Korea CV 즐겨찾기

Symposium 15 : November 19 (Thu), 15:10-16:40
Optimizing surgical outcomes in perihilar cholangiocarcinoma

• Role of ERCP and EUS in resectability assessment Seong-Hun Kim
  Jeonbuk National University, Korea CV 즐겨찾기
• POC-guided mapping biopsy for longitudinal tumor spread Hirofumi Kogure
  Nihon University, Japan CV 즐겨찾기
• Neoadjuvant chemotherapy: Ready for prime time? Young Hoon Choi
  Sungkyunkwan University, Korea CV 즐겨찾기
• Expanding the limits of resectability before major hepatectomy Seok-Hwan Kim
  Chungnam National University, Korea CV 즐겨찾기